Phase 1 — Early testing in a small group of people (usually 20–80) to evaluate safety, determine safe dosage, and identify side effects.
Trial locations(10 sites)
United States
University of Colorado Denver Anschultz Medical Campus, Aurora, Colorado Florida Cancer Specialists, Sarasota, Florida Community Health Network, Indianapolis, Indiana Start Midwest, Grand Rapids, Michigan Swedish Cancer Institute, Seattle, Washington